Acute Hypokalaemia Protocol Replace · Replenish · Resolve · v1.0
⚙ Workflow: Enter the patient's potassium level, ECG findings, magnesium status, symptoms, and clinical modifiers. The tool will generate a stepwise replacement protocol with route selection, rate calculations, magnesium co-correction, and a monitoring plan.
1. Biochemical & Electrical Status
2. Magnesium & Symptom Status
3. Access & Tolerance
4. Clinical Modifiers
5. Suspected Underlying Cause
The Magnesium Gate: Why K Won't Rise Without Mg

This is the single most important concept in hypokalaemia management. Approximately 40 to 60% of hypokalaemic patients are concurrently hypomagnesaemic, and hypokalaemia is refractory to potassium replacement until magnesium is corrected. The mechanism: magnesium depletion activates ROMK (Renal Outer Medullary Potassium) channels in the distal nephron, causing ongoing renal potassium wasting regardless of how much KCl is administered. You will pour potassium in and the kidneys will pour it out. Always check and correct magnesium first.

⚠ The Most Common Reason for "Resistant" Hypokalaemia:
If you have given multiple doses of KCl and the potassium is not rising, the most likely cause is uncorrected hypomagnesaemia. Check serum magnesium immediately. Do not keep escalating KCl doses before fixing the magnesium.
The Digoxin-Hypokalaemia Interaction

Digoxin and potassium compete for the same binding site on the Na+/K+-ATPase pump. When serum potassium falls, digoxin binding to the pump increases dramatically, even at therapeutic digoxin levels. This means a patient with a "normal" digoxin level can develop frank digoxin toxicity purely because their potassium dropped. Clinical features include nausea, visual disturbances (yellow-green halos), and lethal arrhythmias (bidirectional VT, accelerated junctional rhythm, atrial tachycardia with block). In any patient on digoxin, hypokalaemia is a medical emergency requiring urgent correction.

⚠ Clinical Rule: In patients on digoxin, maintain serum K+ above 4.0 mEq/L at all times (not just above 3.5). This is a higher threshold than the general population. The target is 4.0 to 5.0 mEq/L.
IV KCl: Rate, Concentration & Safety Limits

Intravenous potassium chloride is a high-alert medication. Errors in rate or concentration cause fatal hyperkalaemia and cardiac arrest. The following limits are absolute:

Parameter Peripheral IV Central Line Cardiac Arrest
Maximum Rate 10 mEq/hour 20 mEq/hour 40 mEq/hour (ICU only)
Maximum Concentration 40 mEq/L 60 to 80 mEq/L As per protocol
Preferred Diluent Normal Saline (0.9% NaCl). Never use dextrose-containing fluids - insulin release from dextrose drives K+ intracellularly and worsens hypokalaemia.
Monitoring Repeat K+ every 4 h Continuous telemetry + K+ every 2 h Continuous telemetry + K+ every 1 h
⚠ NEVER administer undiluted IV KCl as a bolus push.
This causes instantaneous local hyperkalaemia in the cardiac conduction system, leading to VF and death within seconds. KCl must always be diluted and infused at a controlled rate.
⚠ Peripheral IV Phlebitis:
KCl concentrations above 40 mEq/L through peripheral veins cause severe phlebitis and pain. If the patient reports burning at the IV site, slow the rate or dilute further. Adding 1 to 2 mL of 2% Lidocaine to the infusion bag can reduce pain but is not universally practised.
Oral Potassium Replacement

Oral replacement is safer, more physiological, and preferred whenever the patient can tolerate it. Oral KCl is absorbed efficiently and carries a lower risk of overshoot than IV administration. Common preparations in India:

Preparation Indian Brands K+ Content Notes
KCl syrup (elixir) Potklor, K-Lor 20 mEq per 15 mL Bitter taste. Mix with juice. Commonest form in Indian hospitals.
KCl slow-release tablets K-Dur, Span-K 8 mEq (600 mg) per tablet Better tolerated. Do not crush (defeats slow-release mechanism).
Potassium Citrate Urocit-K, Polycitra-K Variable Preferred in RTA / metabolic acidosis (provides alkali). Not ideal for routine replacement.

GI side effects (nausea, vomiting, abdominal cramps, diarrhoea) are the main limitation of oral KCl and are dose-related. Dividing the dose across the day (e.g. 20 mEq TDS with meals) reduces GI intolerance significantly.

ECG Progression of Hypokalaemia

ECG changes in hypokalaemia are progressive but may not correlate tightly with the serum K+ level. Some patients develop arrhythmias at relatively mild levels, especially on digoxin or with concurrent hypomagnesaemia.

Stage ECG Finding Typical K+ Range Clinical Significance
Early ST segment depression, T wave flattening 3.0 - 3.5 mEq/L Subtle and easily missed. Compare with prior ECGs.
Moderate Prominent U waves (best seen in V2-V3), apparent QT prolongation (actually QU prolongation) 2.5 - 3.0 mEq/L U wave is the hallmark ECG finding of hypokalaemia. May be confused with a long QT.
Severe T-U wave fusion, ST depression deepens, PR prolongation 2.0 - 2.5 mEq/L Increased risk of atrial and ventricular ectopy.
Life-threatening VT, VF, Torsades de Pointes, asystole < 2.0 mEq/L Cardiac arrest. Often triggered by concurrent hypomagnesaemia or digoxin.
Total Body Potassium Deficit Estimation

Serum potassium represents only 2% of total body potassium (the rest is intracellular). Therefore, serum levels significantly underestimate total body depletion. The following approximation is widely used but is only a rough guide:

Serum K+ (mEq/L) Approximate Total Body Deficit Clinical Implication
3.0 - 3.4 100 - 200 mEq Usually correctable with oral replacement over 24 to 48 hours.
2.5 - 2.9 200 - 400 mEq May require combined oral and IV therapy. Takes 2 to 3 days to fully correct.
2.0 - 2.4 400 - 600 mEq Significant deficit. IV therapy required. Full correction takes 3 to 5 days.
< 2.0 > 600 mEq Massive deficit. Aggressive IV replacement with continuous monitoring. May take a week.
Key Principle: Total body deficit cannot be corrected in a single infusion. The initial goal is to raise serum K+ to a safe level (> 3.0 mEq/L) rapidly, then complete the full replacement over 2 to 5 days. Do not attempt to give 400 mEq in 24 hours - the rate limits exist for a reason.
Differential Diagnosis of Hypokalaemia
Transcellular Shift Renal Losses GI Losses Inadequate Intake
Insulin therapy / DKA treatment Loop diuretics (Furosemide) Diarrhoea (most common GI cause) Alcoholism / malnutrition
Beta-2 agonists (Salbutamol) Thiazide diuretics (HCTZ) Vomiting / NG suction (causes renal loss via metabolic alkalosis) Anorexia nervosa
Metabolic alkalosis Hyperaldosteronism (Conn syndrome) Laxative abuse Tea-and-toast diet (elderly)
Thyrotoxic periodic paralysis Cushing syndrome / exogenous steroids Villous adenoma of colon Prolonged NPO without K supplementation
Hypothermia / refeeding syndrome RTA Type 1 and Type 2 Fistulae / ostomy output
Bartter / Gitelman syndrome
Amphotericin B / Cisplatin nephrotoxicity
Diagnostic Pearl: A spot urine potassium or a transtubular potassium gradient (TTKG) can help distinguish renal from extra-renal losses. Spot urine K+ > 30 mEq/L in the setting of hypokalaemia suggests renal wasting. TTKG > 4 in hypokalaemia suggests inappropriate renal potassium secretion (aldosterone excess, diuretics).
DKA and Hypokalaemia: The Insulin Trap

In diabetic ketoacidosis, the total body potassium is always depleted (typically by 200 to 600 mEq) even if the presenting serum K+ is normal or even high. This is because acidosis and insulin deficiency shift potassium out of cells, masking the true deficit. When insulin is started to treat DKA, potassium moves rapidly back into cells and serum K+ can plummet within minutes.

⚠ Critical DKA Rule (ADA/ICMR Protocol):
Do NOT start insulin if serum K+ is below 3.3 mEq/L. Replace potassium first (20 to 40 mEq/hour IV KCl) until K+ is above 3.3, then start insulin. If K+ is 3.3 to 5.3, add 20 to 30 mEq KCl to each litre of IV fluid. If K+ is above 5.3, hold KCl but recheck every 2 hours. Insulin will unmask the deficit.
Abbreviations: K+ (Potassium) · Mg (Magnesium) · ECG (Electrocardiogram) · KCl (Potassium Chloride) · MgSO4 (Magnesium Sulphate) · CKD (Chronic Kidney Disease) · DKA (Diabetic Ketoacidosis) · RTA (Renal Tubular Acidosis) · ROMK (Renal Outer Medullary Potassium channel) · VT (Ventricular Tachycardia) · VF (Ventricular Fibrillation) · TdP (Torsades de Pointes) · TTKG (Transtubular Potassium Gradient)
Algorithm References & Evidence Base
  1. Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7(2):75-84.
  2. Crop MJ, Hoorn EJ, Lindemans J, Zietse R. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients. Nephrol Dial Transplant. 2007;22(12):3471-3477.
  3. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649-2652.
  4. Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135-R146.
  5. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343.
  6. Indian Council of Medical Research (ICMR). Standard Treatment Workflows - Electrolyte Emergencies. 2019.
  7. Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2015;92(6):487-495.
  8. Palmer BF, Clegg DJ. Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019. Am J Kidney Dis. 2019;74(5):682-695.
How to Cite This Tool

AMA Style:
Umakanth S. Acute Hypokalaemia Protocol. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. Acute Hypokalaemia Protocol [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

⚠ Disclaimer: This decision-support system is intended for healthcare professionals. It does not substitute clinical judgment. These algorithms are evidence-based, but medical knowledge evolves continuously. The treating physician retains absolute responsibility for all diagnostic, dosing, and therapeutic decisions. Always verify outputs against current institutional protocols and individual patient contexts.
© 2026 MEDiscuss.org. All rights reserved. This CDSS Module was designed and developed by
Dr. Shashikiran Umakanth using the available evidence base. Provided free of charge for clinical use. Unauthorised reproduction or redistribution is strictly prohibited.
Category Therapeutic Pathways & Algorithms
Specialties Internal Medicine, Nephrology, Critical Care
Status New Pathway
Related Clinical Tools
Acute Hypomagnesaemia ProtocolAcute Hyperkalaemia ProtocolDKA & HHS Management
Back to All Medical Calculators & Pathways